https://apnews.com/02b977b3ed5cfa59643bef1baabde4f7

Vaccine maker Novavax said Monday its shot was highly effective against COVID-19 and also protected against variants in a large, late-stage study in the U.S. and Mexico.

The vaccine was about 90% effective overall and preliminary data showed it was safe, the company said.